Bliss GVS Pharma announced that the 39th Annual General Meeting(AGM) of the company will be held on 25 July 2024.Powered by Capital Market - Live News

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 2 May 2024, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net loss of Bliss GVS Pharma reported to Rs 9.15 crore in the quarter ended March 2024 as against net profit of Rs 3.34 crore during the previous quarter ended March 2023. Sales rose 7.22% to Rs 198.13 crore in the quarter ended March 2024 as against Rs 184.78 crore during the previous quarter ended March 2023.For the full year,net profit rose 6.48% to Rs 75.45 crore in the year ended March 2024 as against Rs 70.86 crore during the previous year ended March 2023. Sales rose 2.48% to Rs 770.24 crore in the year ended March 2024 as against Rs 751.59 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales198.13184.78 7 770.24751.59 2 OPM %14.313.38 -19.5515.61 - PBDT32.104.13 677 172.45124.74 38 PBT25.25-0.75 LP 146.07106.07 38 NP-9.153.34 PL 75.4570.86 6 Powered by Capital Market - Live News

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 2 May 2024.Powered by Capital Market - Live News

Net profit of Bliss GVS Pharma declined 1.18% to Rs 27.61 crore in the quarter ended December 2023 as against Rs 27.94 crore during the previous quarter ended December 2022. Sales declined 2.43% to Rs 200.72 crore in the quarter ended December 2023 as against Rs 205.72 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales200.72205.72 -2 OPM %21.7723.18 - PBDT47.0052.07 -10 PBT40.0447.43 -16 NP27.6127.94 -1 Powered by Capital Market - Live News